According to GenSight Biologics's latest financial reports the company's current earnings (TTM) are -S$37.76 M. In 2023 the company made an earning of -S$37.76 M an increase over its 2022 earnings that were of -S$38.59 M.The earnings displayed on this page is the company's Pretax Income.